Acadia Pharmaceuticals
Edit

Acadia Pharmaceuticals

http://www.acadia-pharm.com/
Last activity: 19.03.2026
Active
Categories: DrugFamilyHealthTechInformationJobMedTechMessangerPersonalRecruitingTalent
As a leader in developing and commercializing innovative therapies for central nervous system disorders we are committed to improving the lives of patients.
Website visits
11.8K /mo.
Mentions
20
Employees: 501-1000
Total raised: $86.4M
Founded date: 1993

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
12.12.2012-$86.4M-

Mentions in press and media 20

DateTitleDescription
21.03.2026Condor Software Secures $24M to Revolutionize Life Sciences Financial IntelligenceCondor Software, a San Diego innovator, secured $24 million in Series A funding. This pivotal round, led by Insight Partners, propels the company's total capital to $36 million. Condor fundamentally transforms life sciences financial operat...
19.03.2026Condor Software: $24 Million Raised To Build Financial Intelligence Platform For Life SciencesCondor Software announced it has raised $24 million in a Series A funding round led by Insight Partners, with participation from Felicis, 645 Ventures, Pamir Ventures, SNR Ventures, Prebys Ventures, and Bramalea Partners. The company has no...
22.06.2025A revolutionary drug for extreme hunger offers clues to obesity’s complexityBut what’s becoming clear is that obesity isn’t one disease — it’s many, said Jack Yanovski, a senior obesity researcher at the National Institutes of Health, who co-authored some of the Vykat XR studies. Researchers are learning that obesi...
12.03.2025Saniona’s new CMO to BioStock: “More deals are definitely on the horizon”Saniona’s new CMO to BioStock: “More deals are definitely on the horizon” Wed, Mar 12, 2025 11:49 CET Report this content Saniona has appointed Pierandrea Muglia, M.D., as Chief Medical Officer, bringing over three decades of expertise from...
07.03.2025BioStock: Saniona’s CEO comments on the recent newsBioStock: Saniona’s CEO comments on the recent news Fri, Mar 07, 2025 09:25 CET Report this content Saniona is advancing its treatments for epilepsy and neurological disorders, with SAN2355 – a selective epilepsy therapy – now in GMP-manufa...
28.02.2025BioStock: Saniona strengthened its cash position and advanced through partnershipBioStock: Saniona strengthened its cash position and advanced through partnership Fri, Feb 28, 2025 09:54 CET Report this content Saniona’s key milestone in 2024 was securing an exclusive worldwide licensing agreement with Acadia Pharmaceut...
24.02.2025BioStock: Saniona’s CEO responds to investors’ questionsBioStock: Saniona’s CEO responds to investors’ questions Mon, Feb 24, 2025 10:30 CET Report this content Saniona’s collaboration with Acadia Pharmaceuticals, signed in November, marked a significant milestone for the company. With a total p...
10.02.2025Live interview with Saniona tomorrow – submit your questions!Live interview with Saniona tomorrow – submit your questions! Mon, Feb 10, 2025 11:10 CET Report this content Saniona made the headlines late last year when the company entered a partnership with Acadia Pharmaceuticals, a deal worth up to 6...
17.06.2024CARINGKIND RAISES $1.4 MILLION IN SUPPORT OF ALZHEIMER'S AND RELATED DEMENTIA CARE AT THE 28TH ANNUAL FORGET-ME-NOT GALANEW YORK, June 17, 2024 /PRNewswire/ -- CaringKind, the trusted partner in Alzheimer's and related dementia caregiving for over 45 years, hosted their 28th annual Forget-Me-Not Gala on Monday, June 3rd, 2024, at Cipriani 42nd Street. The no...
11.06.2024QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Financial Officer and Appoints Shafique Virani, M.D., to Board of DirectorsIndustry veteran Williamson brings nearly three decades' experience as a leader in neuroscience R&D at organizations including Eli Lilly and Company, Lundbeck, Parexel, and Acadia Pharmaceuticals Former Karuna CFO Brown brings more than...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In